BY MOUTH, BENIGN GASTRIC ULCER, 40 MG DAILY IN THE MORNING FOR 4 WEEKS, CONTINUED FOR FURTHER 4 WEEKS IF NOT FULLY HEALED
GASTRO-OESOPHAGEAL REFLUX DISEASE, 20 - 40 MG DAILY IN THE MORNING FOR 4 WEEKS, CONTINUED FOR FURTHER 4 WEEKS IF NOT FULLY HEALED; MAINTENANCE 20 MG DAILY, INCREASED TO 40 MG DAILY IF SYMPTOMS RETURN
DUODENAL ULCER, 40 MG DAILY IN THE MORNING FOR 2 WEEKS, CONTINUED FOR FURTHER 2 WEEKS IF NOT FULLY HEALED
DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI, SEE RECOMMENDED REGIMENS FOR HELICOBACTER PYLORI ERADICATION
PROPHYLAXIS OF NSAID-ASSOCIATED GASTRIC OR DUODENAL ULCER IN PATIENTS WITH AN INCREASED RISK OF GASTRODUODENAL COMPLICATIONS WHO REQUIRE CONTINUED NSAID TREATMENT, 20 MG DAILY
ZOLLINGER-ELLISON SYNDROME (AND OTHER HYPERSECRETORY CONDITIONS), INITIALLY 80 MG ONCE DAILY ADJUSTED ACCORDING TO RESPONSE (ELDERLY MAX. 40 MG DAILY); DAILY DOSES ABOVE 80 MG GIVEN IN 2 DIVIDED DOSES
BY INTRAVENOUS INJECTION OVER AT LEAST 2 MINUTES OR BY INTRAVENOUS INFUSION, DUODENAL ULCER, GASTRIC ULCER, AND GASTRO-OESOPHAGEAL REFLUX, 40 MG DAILY UNTIL ORAL ADMINISTRATION CAN BE RESUMED
ZOLLINGER-ELLISON SYNDROME (AND OTHER HYPERSECRETORY CONDITIONS), INITIALLY 80 MG (160 MG IF RAPID ACID CONTROL REQUIRED) THEN 80 MG ONCE DAILY ADJUSTED ACCORDING TO RESPONSE; DAILY DOSES ABOVE 80 MG GIVEN IN 2 DIVIDED DOSES
CHILD NOT RECOMMENDED